Extending FDA-approved cancer drug indications requires high patient numbers, study finds Post author: Post published:September 29, 2023 Post category:uncategorized Number of patient participants needed for secondary approval of a new cancer drug. You Might Also Like Bioactive glasses with gallium show promise for bone cancer treatment September 10, 2024 Cultivating strength: How yogurt boosts skeletal muscle health October 16, 2023 New insights into physical activity adoption for rheumatic patients June 13, 2024